DSIP (Delta Sleep-Inducing Peptide) – Neuropeptide

Product Overview

DSIP (Delta Sleep-Inducing Peptide) is a highly specialized, naturally occurring nonapeptide originally isolated from the cerebral venous blood of rabbits during slow-wave sleep. Despite its name, advanced research indicates that DSIP functions less as a simple sedative and more as a sophisticated sleep normalizer and neuromodulator. It is utilized in cutting-edge research to study the restoration of disrupted sleep architecture, the enhancement of restorative slow-wave (delta) sleep, and the modulation of neuroendocrine stress responses.

Technical Specifications

• Molecular Formula: C35H48N10O15

• Molecular Weight: 848.82 g/mol

• CAS Number: 62568-57-4

• Sequence Profile: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

Mechanism of Action

DSIP exerts profound, long-lasting neuromodulatory effects through unique pathways that persist far beyond its rapid initial clearance:

• Sleep Architecture Normalization: Rather than forcing sedation, DSIP modulates sleep-wake transitions by interacting with GABAergic, serotonergic, and dopaminergic pathways. This targeted activity specifically increases the duration and efficiency of Stage 3 NREM (slow-wave/delta) sleep—the deepest phase required for tissue repair and memory consolidation.

• Neuroendocrine Modulation: Synchronizes endogenous growth hormone (GH) secretory patterns and normalizes disrupted luteinizing hormone (LH) pulsatility, aligning critical hormone release with restored slow-wave sleep cycles.

• Analgesic & Opioid System Interaction: Interacts with endogenous opioid systems to modulate enkephalin and beta-endorphin signaling, providing notable pain-modulating properties without the addiction liability of exogenous opioids.

• The Pharmacokinetic Paradox: While rapidly degraded by blood enzymes (cleared in minutes), DSIP crosses the blood-brain barrier via a saturable transport system to trigger persistent gene expression and neurotransmitter dynamic shifts that last for days to weeks.

Primary Research Applications

DSIP is a premier compound for in vitro and animal model studies investigating:

• Sleep Architecture Optimization and Insomnia Normalization

• Slow-Wave (Delta) Sleep Enhancement and Glymphatic Clearance

• Neuroendocrine Regulation (Growth Hormone and LH pulsatility synchronization)

• Analgesia and Chronic Pain Modulation

• Circadian Rhythm Restoration and Shift Work/Jet Lag Models

Storage & Handling

For optimal long-term stability and structural integrity, store lyophilized powder securely at -4°F (-20°C). Reconstituted solutions should be kept refrigerated at 36°F to 46°F (2°C to 8°C) and utilized within defined lab-specific timelines.

⚠️ Important Disclaimer for Carbon Nova Labs Customers: All information provided is for educational and reference purposes only. DSIP is sold strictly for laboratory research use only. This compound is not approved by the FDA for human consumption, therapeutic use, or clinical application. Ensure compliance with all institutional safety protocols and consult qualified professionals before conducting research.